Mylan Says It Upgraded EpiPen in 2009. So Experts Looked Inside.: In her sworn testimony before the House Committee on Oversight and Government Reform last week, Mylan's CEO said most of the money the company had spent on EpiPens went towards marketing and lobbying.
Бузову уличили в�примитивном плагиате мирового бренда | Новости | Пятый канал https://www.5-tv.ru/news/204006/